Chemical Structure (Nexlizet 01)
This is not-available as the text is incomplete and does not provide enough information to generate a useful description.*
Nexlizet Tablet, Film Coated
Product Images NDC 72426-818
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nexlizet (NDC 72426-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Esperion Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Nexlizet 02)
Principal Display Panel (180 mg/10 mg Tablet Bottle Label)
This is a description of a medication called NEXLIZET, which is a combination of 180mg bempedoic acid and 10mg ezetimibe. The medication comes in tablet form and should be stored at 20°C to 25°C, with some fluctuations allowed. It is important to keep the medication in its original packaging and protect it from extreme heat and humidity. The manufacturer is Esperion Therapeutics, Inc. and the dosage and administration information can be found in the accompanying package insert. The medication is manufactured in India with bempedoic acid originating from the USA and ezetimibe originating from India. The NDC number for this medication is 72426-818-03 and it is only available with a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
